CF
ENZ

Centaurus Financial’s Enzo Biochem, Inc. ENZ Stock Holding History

Centaurus Financial’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-1,000
Closed -$5K – 2109
2018
Q2 		$5K Buy
+1,000
New +$6.09K ﹤0.01% 1830

Other funds holding ENZ

EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Centaurus Financial's ENZ Position: Q3 2018 in Review

Centaurus Financial sold out of Enzo Biochem, Inc. (ENZ) in Q3 2018, closing a stake of 1,000 shares — an estimated $5K sold.

Centaurus Financial first reported a position in ENZ in Q2 2018 and held it in 1 quarter. The position peaked at $5K in Q2 2018. 101 funds tracked by Wall St. Rank hold ENZ as of Q3 2018.

  • Centaurus Financial reported no remaining Enzo Biochem, Inc. position as of Q3 2018 after selling out during the quarter.
  • Centaurus Financial sold 1,000 Enzo Biochem, Inc. shares in Q3 2018, an estimated $5K.
  • Centaurus Financial first reported a position in Enzo Biochem, Inc. in Q2 2018 and held it in 1 quarter.
  • Centaurus Financial's Enzo Biochem, Inc. position peaked at $5K in Q2 2018.
  • 101 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2018.

Based on Centaurus Financial's 13F filing for Q3 2018, filed 5 Nov 2018.